IEHI!!HVALLEY
HOSPn'AL

Medical Staff

Progress Notes
From the
President

In This Issue ...
PHAMIS News
• Page 3
Spectmm
Apothecary
Changes
• Page 5
WalkAmerica
• Page 6
Health Network
Laboratories News
• Pages 17-19
P & T Highlights
• Zl-25

Although we
have all been
inconvenienced for several weeks by
the loss of lab results on PHAMIS, I
am happy to report that as of April 7,
lab results are again available through
PHAMIS. The problem arose with
questions of confidence and the results
being displayed for individual patients.
We applaud the labors of our I/S and
Laboratory staff who diligently worked
many hours to "find the fix" and test
and re-stress the system to reestablish
our confidence in lab results. It is a
mark of our concern and dedication to
quality patient care that we endured
these hardships until confidence was
reestablished.
Work on various search committees
continues. The candidate for Chair of
Surgery, Dr. Robert Bower, will be
making a visit this week before
rendering his decision. The search for
Chief Operating Officer continues, and
we are gratified by the high quality
candidates interested in our institution.
We initially interviewed four
candidates. Two have been selected to
return in the next few weeks for twoday visits. Also, work on the Chief of
Clinical Services has begun, with a
revision of job description and paper
review of interested candidates.
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Hopefully, on-site visits and interviews
will begin shortly.
Functional planning continues at a
scheduled pace. Plans for the areas on
the first floor for the new GI Lab and
Pre-admission Testing, as well as the
ER Fast Track site on the second floor
(current location of Medical Staff
Services) are proceeding according to
schedule. At 17th & Chew, the fourth
floor renovation for OB/GYN is
underway. We have signed-off on the
development of the Ambulatory/
Surgical wing, and a visit by state
health officials to review the skilled
nursing facility plans will take place in
the next few weeks.
Congratulations to our training
programs in surgery, OB/GYN, and
medicine. The results of the match
continue to indicate interest among
medical students in our programs, and
places us competitively with the nations
training programs. Our departments
and divisions should be proud.
Several of our departments and
divisions have held discussions and
conferences with our colleagues at
Penn State's College of Medicine at
The Milton S. Hershey Medical
Center. Neurology has begun clinical
conferences while orthopedic
Continued on Page 2
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physicians and division chiefs at our
institution met with their counterparts
at Penn State's College of Medicine.
This is an ideal way to share programs
and ideas and develop a true working
relationship with our medical school
affiliation. Congratulations to those
who have already started the process,
and I encourage all of us to explore
avenues for discussion, cooperation,
conferences, etc.
On the managed care front, I am

pleased to report that Prudential has.
contracted with Lehigh Valley Hosp1tal
for their global cardiac program. This
task was not easy, and much credit
needs to be given to the Divisions of
Cardiothoracic Surgery and
cardiology' the Department of
Surgery, and Administration who
worked with Prudential representatives
to secure this contract for our
institution. Also, in the managed care
arena, Jack A. Lenhart, M.D., family
practitioner, and John Jaffe, M.D.,
urologist, have agreed to serve as
Medical Directors of our PhysicianHospital Organization. Lawrence P.
Levitt, M.D., neurologist, has accepted
the position to chair the Care
Management Committee. As we all
know, we believe that the care
management arm is the essential pi~
in promoting our PHO to employers m
our community. We appreciate Jack's,
John's, and Larry's acceptance of these
positions and are very confident in
their abilities to direct the IPA/PHO.

Physical Therapy to decrease length of
stay. Impressive data can be obtained
for your review from Peter Keblish,
Jr., M.D., Chief of the Division of
Orthopedics, or any of the orthopedic
surgeons. Also, transcription
turnaround time is improving, and we
are continuing to work to achieve our
goal of hard copy on the chart by 7
a.m. the following day. Hard copy lab
results have also been available at
earlier times in. presence of the current
PHAMIS problem. Our lab staff has
worked hard to provide us with lab
data as soon as it is available.
Finally, I wish to thank Dick Fleming
for his presentations to the General
Medical Staff in March, to the Medical
Executive Committee, and to members
of our Medical Staff regarding the
Cardiothoracic Surgery issues. We all
have much concern for the future;
however, I believe, that if we as a
Medical Staff within our departments
and divisions take ownership of patient
care by addressing high standards of
care for our patients, then we truly
become aligned in our ultimate purpose
-- quality patient care.
Best Wishes and Happy Spring,

A. Candio, M.D.
ident, Medical Staff

Medical Staff participation in the
Operations Improvement Program are
highlighted by our Orthopedics
Division working with Nursing and
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A Reminder from Lehigh Valley Pharmaceutical
Association
The hospital recently received notice
from the Lehigh Valley Pharmaceutical
Association about an old problem
which seems to be growing again.
Prescriptions containing no
identification of the prescriber, other
than a sometimes illegible signature,
are being presented to pharmacists in
the area. This often results in delays
for the patient as the pharmacist tries
to track down the prescriber. The
valuable time of physicians and
hospital personnel is often wasted in
the process. This problem is especially
acute with the physicians in the various
residency programs at area hospitals.

~

This situation is easily prevented by
having the prescriber's name preprinted
on the prescription blank or by the use
of a stamp containing the prescriber's
name when using a hospital blank. In
fact, Pennsylvania Act 1980-86,
Section 1. (a) states, "The name of the
physician writing a prescription for a
drug shall be printed or stamped on the
prescription form in addition to his
signature."
Please keep this in mind when you are
writing prescriptions. Your
cooperation is very much appreciated.

PHAMIS LastWord News
To date, 30 offices have been
connected to the PHAMIS network
representing 144 physicians and 37
work stations. Each month,
approximately 250 physicians utilize
the PHAMIS LastWord system more
than 6,500 times to access our
expanding clinical data base.
Information Services is now accepting
orders for physician office connections
on a first-come, first-served basis.
Please contact Information Services at
402-1400 to initiate this process.
Following is the schedule of classes for
PHAMIS LastWord training for
physicians, residents, and allied health
personnel:
}

• Tuesday, May 3- 1 to 3 p.m.
• Tuesday, May 10- 6 to 8 a.m.

•
•
•
•
•
•
•

Tuesday, May 17- 5 to 7 p.m.
Thursday, June 9- 6 to 8 a.m.
Wednesday, June 15- 1 to 3 p.m.
Tuesday, June 21 - 5 to 7 p.m.
Thursday, July 7- 6 to 8 a.m.
Tuesday, July 12 - 1 to 3 p.m.
Wednesday, July 20 - 5 to 7 p.m.

All classes will be held at 17th &
Chew in the School of Nursing on the
first floor.

To register for a class or if you have
any questions, please contact Diann
Brey in Information Services at
402-1404.
Information Services welcomes your
continued feedback and support.
Please call 402-1404 for training/
refresher information or 402-8303 for
the Help Desk.
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Heparin Resistance

Laboratory
Update

Prof"de

+ Glynn MFX. Heparin monitoring
and thrombosis. Am I Clin Pathol
1979; 71:397-400.

While a patient is receiving heparin,
you may occasionally run into a
situation where the activated partial
thromboplastin time (APTT) does not
become as prolonged as would be
expected while the patient is receiving
intravenous heparin. This may occur
.for one of four reasons:

+ Levine SP, Sorenson RR, Harris
MA, Kniefiem LK. The effect of
platelet factor 4 on assays of plasma
heparin. Br J Haematol 1984; 57:585596.

•
•
•
•

Elevated factor I (Fibrinogen)
Increased factor Vlli
Decreased antithrombin lli level
Elevated platelet factor IV

When this clinical situation occurs, a
plasma heparin determination is
warranted to avoid over-heparinization
with the resultant increased propensity
for hemorrhage to occur.
Whenever the APTT results are lower
than expected, a plasma heparin assay
may be indicated to provide both a
more accurate and safer monitoring of
heparin therapy. To prove that the
decreased APTT response is due to one
of the above mentioned causes,
monospecific factor assays can be
performed for factors I, Vlll,
Antithrombin ill, and platelet factor
IV. In this instance, order a Heparin
Resistance Prortle. The Heparin
Resistance Prorde consists of the
following tests:
•
•
•
•
•

Factor I level
Factor Vill level
Antithrombin ill level
Platelet factor IV level
Plasma heparin level

Additional information can be found in
the references as listed below:

+ Marciniak E, ·Gockerman IP .
Heparin-induced decrease in circulating
antithrombin m. Lancet 1977; 2:581584.

+ Holm HA, Kalvenes S,

Abildgaard
U. Changes in plasma antithrombin
during intravenous heparin therapy:
Observations in 198 patients with deep
venous thrombosis. Scand I Haemost
1985; 35:564-569.

+

Marci CD, Prager D. A review of
the clinical indications for the plasma
heparin assay. Lippincott 1993;
99:547-550.
If you have any questions regarding
this issue, please contact David Prager,
M.D., Medical Director, Hematology/
Coagulation Laboratory, at 433-6691,
or Dolores Benner, Supervisor,
Hematology/Coagulation, at 402-8177.

··.··•··UR~aS~t.biiNilu~·········•··•······•············ .

t;:Stillii~!il

:; i4t~--~~'~,;~j(
Page 4

)

Spectrum Apothecary Changes
On Friday, April 8, Spectrum

Apothecary closed its doors for the last
time in its location at 1230 S. Cedar
Crest Boulevard. On Monday, April
11, a new pharmacy, known as Health
Spectnun Pbarmacy Services, opened
its doors in its new location, just off
the atrium of the John and Dorothy
Morgan Cancer Center.
This move is in response to Health
Spectrum's continued growth as a
provider of high tech home care
services. In addition to everyday
prescription services, Health

Spectrum Pharmacy Services
specializes in home intravenous
therapies and is staffed by pharmacists,
nurses, and technicians specializing in .
these areas.
Hours of operation are Monday,
Wednesday, and Thursday - 8:30 a.m.
to 5:30p.m.; Tuesday and Friday7:30a.m. to 5:30p.m.
For more information about the
services offered, contact Health
Spectrum Pharmacy Services at
402-8444.

Infection. Control Consultation Services
The Infection Control Department of
Lehigh Valley Hospital has recently
developed a series of consultative
services to cover a wide variety of
needs.

For more information or a copy of the
brochure, please contact Andrea
Geshan, Director of the Infection
Control Department and AIDS
Activities Office, at 402-2413.

Activities offered through the services
include:
• Evaluation of standard infection
control practices
• Recommendations for program
improvements
• Evaluation or development. of
exposure control plans
• Provision of training programs
A brochure which provides a complete
description of the program is available
through the Infection Control
Department.
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WallcAmerica for Healthier Babies
On Sunday, April24, it's time for
WalkAmerica for Healthier Babies,
the nation's largest annual walk and
fundraiser for the March of Dimes.
This event raises money so that more
babies will be born healthy.
The success of WalkAmerica is
important to the March of Dimes and
to Lehigh Valley Hospital. Over the
past 13 years, our hospital has received
almost $300,000 in grants from the
March of Dimes. We've used these
dollars to purchase equipment and
provide community programming.
Lehigh Valley Hospital is getting
involved by forming its own team of
walkers. As friendly competition is
encouraged, challenge one or more of
your colleagues to get the most walkers
and/or collect the most pledges.
Our walkers will receive a hospital
T-shirt and compete for individual and
team prizes:
• The person raising the most pledges
wins two tickets to a 1994 Penn State
football game

News from Research
A call for abstracts has been issued by
the following organizations:
• The American Heart Association for
the 67th Scientific Sessions of the
American Heart Association to be held
on November 14, 1994 in Dallas,
Texas. Submission due date is May 6.

• The team raising the most pledges
wins a gift basket
• The team with the most walkers
wins a gift basket
• The youngest actual walker wins a
Dorney Park season pass
• The oldest actual walker wins a
. dining/entertainment book
• Individuals raising $200 or more in
pledges will receive a Lehigh Valley
Hospital sports bottle, fanny pack, and
towel.
Walk with us through the beautiful
Lehigh Parkway, Union Terrace, and
Cedar Beach. Together our team will
walk seven miles to raise monies that
are invested right here in the Lehigh
Valley. Join Dr. Sussman and his
family, your colleagues and friends on
Sunday, April24. Let's all put our
best foot forward for this worthwhile
cause.
For more information or to register,
contact -Gail Pitsko, Lehigh Valley
Hospital WalkAmerica Team Captain,
in Public Relations, at 402-3001.

• The International Society for
Pharmacoepidemiology for the lOth
International Conference on
Pharmacoepidemiology to be held in
Stockholm, Sweden on August 28,
1994. Submission due date is May 20.
For instructions, forms, and further
information, please contact Kathleen
Moser in the Research Department at
402-8747.
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Clinical
Nutrition

News

Nutrition Management
of the HIV Patient
by Donna Scott, R.D.

Historically, nutrition has not been
considered standard therapy in
treatment of patients with HIV.
However, nutrition intervention is
becoming recognized as a key therapy
in combating HIVI AIDS. One of the
primary physiological considerations in
HIV-infected patients is malnutrition.
Malnutrition can exacerbate diminished
immune function or independently
minimize the quality of life and
increase morbidity. Nutritional status
can be reflective in the way patients
respond to other therapies and
medications. Well-nourished patients
have a better quality of life and
increased longevity. Early nutrition
intervention may delay or prevent
malnutrition and muscle wasting.
Good nutrition will promote optimal
functioning in all of the different
systems, including the immune system.
Complications from other physiological
changes that occur in HIVI AIDS
patients can be circumvented by
nutrition intervention. The metabolic
rate increases with the disease,
therefore, the needs for increased
calorie diet will help maintain body
weight and preserve lean body mass.
Some complications associated with
HIV disease that can be improved/
treated with nutrition therapies include
lactose and other food intolerances,
anorexia, vitamin and mineral
deficiencies, gastrointestinal
dysfunctions (n/v/d), dysphagia,
difficulty with dentition and
malabsorption.

Optimal nutrition can help strengthen
the body and prevent tissue breakdown.
What is meant by optimal/good
nutrition for people with HIVI AIDS?
A combination of increased
carbohydrates, increased protein and
moderate fat intake is the key. The
foods selected should be nutrient dense
to provide the right/correct balance of
vitamins and minerals.
A diet that is increased in complex
carbohydrates is recommended (CHO's
are the body's major source of energy
and calories). Small, frequent meals (4
- 6 times/a day) are usually better
tolerated and can help meet metabolic
stresses.
• A complete multi-vitamin and
mineral is recommended/day vs.
megadoses of vitamins and minerals to
provide sufficient essential nutrients.
• Adequate food intake (30 - 35Kcal/
kg) with emphasis on adequate fluid
intake.
• Commercially available nutrition
supplements are available and
recommended when patients are unable
to consume adequate Kcals.
If patients continue with poor P.O.
intake and have a functioning GI tract,
enteral (TF) feeding is recommended.
If unable to utilize GI tract, parenteral
nutrition is recommended.
For more information or for a full
assessment and recommendations,
contact Clinical Nutrition Services at
402-8313 or 402-8378.
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A Cause for Celebration!
It's that time of year again-- Macy's is
hosting its sixth annual Benefit
Shopping Day on Tuesday, April 26,
fro~ 10 a.m. to 10 p.m. at Macy's
Lehigh Valley. For 12 continuous
hours, you can shop amidst extraspecial excitement, with refreshments
and various forms of entertainment
featured on both levels of the store.
In addition to the five discount coupons
included with the purchase of your
ticket, Macy's Benefit Day Shoppers
will be registered to win spectacular
prize packages, including:

•

Holland Vacation for Two (six
days/five nights for two at the
Five-Star Barbizon Centre Hotel
and roundtrip air travel on
KLM Royal Dutch Airlines)

•

Bermuda Get-Away for Two
(seven days/six nights at the
Belmont Hotel, Golf and
Country Club, with unlimited
free golf on the hotel's 18-hole
golf course and complimentary
breakfast each morning)

•

Thanksgiving in New York
(four days/three nights at the
Doral Park Avenue Hotel, VIP
viewing of the Macy' s
~giving Day Parade, and
dmner for two at the Time and
Again Restaurant)

•

$5,000 Shopping Spree in Fine
Jewelry

•

$1,000 Men's Wardrobe

•

$1,000 Women's Wardrobe

•

Housewares Surprise Package

Tickets are $5.00 each, the proceeds of
which will benefit one of three special
programs -- Friends of Nursin&,
l.ehip Valley Hospice, and the John
and Dorothy Morpn Cancer Center
under the auspices of the Lehigh
'
Valley Hospital Trust Fund. Tickets
may be purchased at the Tree Top
Shop (Cedar Crest & 1-78) and the
Alcove Gift Shop (17th & Chew) or at
other off-site locations as follows:
• 1243 S. Cedar Crest- Laurie
Gillespie (402-3031)
• 2166 S. 12th Street - Tracy
Kuhnsman (402-7441)
• 2024 Lehigh Street - Debbie Strauss
(402-1406)
Buy your tickets today to join the fun
and support a great cause!
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News from the Office of Education
All physicians in Pennsylvania must
participate in CME activities sufficient
to (a) fulfill the requirements of the
American Medical Association
Physician's Recognition Award (PRA),
or (b) fulfill the requirements of the
Pennsylvania Medical Society. These
requirements are slightly different, but
each requires participation in a
minimum of 50 hours of CME each
year, of which a minimum of 20 hours
must be designated as Category 1.
Category 1 CME must meet strict
requirements including:
• addressing a defined need
• having specific objectives
determined, based on the need defined

Pool Trust News
OB/GYN Resident Data
CoUection Project Expansion
In May 1993, the Pool Trustees
approved $40,000 toward a project
called the National Resident Data
Collection Study. This study
undertook the development of a system
for resident data collection within the
Department of OB/GYN, with
implications for teaching programs at
Lehigh Valley Hospital and nationally.

At their February meeting, the Pool
Trustees approved funding in the
amount of $15,000 to expand the
OB/GYN Resident Data Collection
project in order to refine the existing
program and to expand the project to
include the Hershey Medical Center's
Department of OB/GYN.

• having teaching methods appropriate
to the objectives
• having defined methods of
evaluation
• demonstrating a budget sufficient to
accomplish the objectives· and program
• being free of commercial bias
These standards are set by the
Accreditation Council for Continuing
Medical Education (ACCME). All
organizations giving Category 1 CME
credit are reviewed by the ACCME or
a society authorized by it.· In the
Lehigh Valley, the Lehigh Valley Area
Health Education Center is accredited
by the Pennsylvania Medical Society to
approve programs for CME Category 1
credit.

RAC Protocols Receive
Funding
The Trustees approved the release of
funds in the amount of $46,814 from
the Institutional Research fund for the
following Research Advisory
Committee (RAC) protocols:
• Disease Activity Follow-up in Patients with
Inflammatory Bowel Disease; PI- James F.
Reed ill, Ph.D., $5,000
• The Effect of Inpatient Compreheasive
Geriatric Assessment Intervention on Patient
Care Outcomes; PI- Lisa Lacko, R.N.,

M.S.N., $32,474
• Health-Related Quality of Life in Adult
Community Acquired Pneumonia; PI - Barbara

A. Salvadore, M.S., $4,500
• Technique for Laparoscopic Vertical Handed
Gastroplasty; PI- Clark Gerhard, M.D.,

$4,840
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Publications, Papers and Presentations
Robert V. Cmmninp, M.D.,
Chairperson, Department of Obstetrics
and Gynecology, Larry R.
Glazerman, M.D., Department of
Obstetrics and Gynecology, and
Stephen K. Klasko, M.D., Vice
Chairperson and OB/GYN Residency
Program Director, presented Re_iden_
Da_a Collec_ion Is Not Just S's and
T's at the 1994 Council on Resident
Education of Obstetrics and
Gynecology and the Association of
Professors of Gynecology and
Obstetrics Annual Meeting held in
Nashville, Tenn., on March 3.
Peter A. Keblisb, M.D., Chief,
Division of Orthopedic Surgery, coauthored an exhibit at the American
Academy of Orthopaedic Surgeons 61st
Annual Meeting held recently in New
Orleans, La. The scientific exhibit's
primary author was Ashok Varma,
M.D., recent Lehigh Valley Hospital
resident, with other co-authors James
F. Reed ill, Ph.D., Director of
Research, and Frederick Buechel,
M.D., Professor of Orthopaedics at
New Jersey Medical Center.

Lehigh Valley Hospital has been part (
of a multi-center study which was
included in the clinical material of the
exhibit. The exhibit addressed the
important aspects of radiologic
assessments of non-cemented total knee
implants as they relate to clinical
practice.

Brian W. Little, M.D., Director of
Education, presented Commercial
Support and Guidance Practice
Parameters at the Pennsylvania
Medical Society's annual CME
conference, CME In A Chan&in&
Healthcare EnviroDDlent, which was
held recently in Harrisburg.
HowardS. Selden, D.D.S.,
endodontist, recently published a paper
titled, Diagnostic Radiop'llpblC
Findings and Symptom-Free Teeth.
The paper appeared in the February
1994 issue of the Journal of

Endodontics.

Upcoming Seminars, Conferences and Meetings
Regional Symposium Series V
Update: Management of Diabetes in
ChDdren will, be presented on
Thursday, April 21, from 1 to 4:30
p.m., in the Auditorium of Lehigh
Valley Hospital, Cedar Crest & I-78.

Physicians, family practitioners,
nurses, and other health care
professionals interested in the
management of diabetes in children
will benefit from this program.
Continued on Page 11
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At the completion of the program,
participants should be able to:
• describe the outcomes associated
with tight control of diabetes mellitus
in children
• discuss the state-of-the-art
prevention, diagnosis, and treatment of
renal complications in juvenile onset
IDDM.
Fourteenth Annual Update in
Cardiology will be presented on
Thursday, May 5, from 7:45a.m. to
12:45 p.m., in the Auditorium of
Lehigh Valley Hospital, Cedar Crest &
1-78.

Physicians and other health care
professionals interested in the la~t
breakthroughs in selected aspects m
cardiology will benefit from this
program.
At the completion of the program, the
participant should be able to:
• identify the usefulness and long term
outcome of coronary atherectomy
• identify the usefulness and long term
outcome of lasers and stents in
coronary disease
• identify the late outcome of coronary
bypass surgery
• treat lipid disorders in at-risk
patients.
Third Annual WUdemess Medicine
Symposium will be presented on
Saturday, May 14, from 7:15a.m. to
4:45p.m., in the Auditorium of
Lehigh Valley Hospital, Cedar Crest &
1-78.

Physicians, nurses, pre-hospital
personnel, and others interested in
wilderness medicine will benefit from
this program.

At the completion of this program, the
participant should be able to:
• describe safety strategies and
survival techniques utilized by hunters
• discuss the prevention, signs, ,
symptoms, and treatment of critical
incident stress in the wilderness
• describe common medical problems
that occur during whitewater activities
• explain techniques for creatively
managing the airway
• discuss the appropriate choice of
clothing for outdoor activities
• describe the prevention and
management of injuries while mountain
biking.
Getting Employees Back to Work:
Alternative Temporary Positiom will
be presented on Friday, May 20, from
8 a.m. to 3:45 p.m., in the Auditorium
of Lehigh Valley Hospital, Cedar Crest
& 1-78.

Physicians, nurses, administrators, and
insurance representatives concerned
with Workers' Compensation costs will
benefit from this program.
At the completion of the program,
participants should be able to:
• identify steps for the development of
a three-phase limited duty program
• discuss examples of reasonable
accommodations for workers with
disabilities in the health care setting
• outline the components and
effectiveness of a team approach for
managing employees return to work.
For more information regarding these
programs, please contact Human
Resource Development at 402-4609.
Continued on Page 12
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Medical Grand Rounds
Ethical Norms for Discontinuing
Artificial Nutrition and Hydration
will be presented by Father William
Carr, Fairfield University, College of
Arts and Sciences, Department of
Philosophy, on Tuesday, April19.
Hypothyroidism - A New Look at an
Old Di!ease will be presented by
Gilbert Daniels, M.D., Associate
Professor of Medicine, Harvard
Medical School, and Attending
Physician, Massachusetts General
Hospital, on Tuesday, April 26.

Medical Grand Rounds are held at
noon in the Auditorium of Lehigh
Valley Hospital, Cedar Crest & 1-78. (
For more information, contact the
Department of Medicine at 402-8200.

Psychiatry Grand Rounds
Non-Epileptic Seizures will be
presented by Alexander Rae-Grant,
M.D., neurologist, on Thursday, April
21, from noon to 1 p.m., in the
Auditorium of Lehigh Valley Hospital,
17th & Chew.

As lunch will be provided, preregistration is requested by calling the
Department of Psychiatry at 402-2810.

News from Health Promotion and Disease Prevention
The Health Promotion and Disease
Prevention Department of Lehigh
Valley Hospital will present several
free public lectures over the next few
months. Sponsored by the Chronic
Disease Education Committee of
Lehigh Valley Hospital, the lectures
include:
Oh, My Aching Back will be
presented by Thomas D. Meade,
M.D., orthopedic surgeon, and Greg
Salem, exercise specialist, on Tuesday,
April 19, from 7 to 8:30p.m., in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & 1-78.

Have you ever motivated yourself to
try a new sport or exercise program,
only to have your interest quickly
dampened because of an injury? With
the proper warm-up, cool-down, and
exercise technique, many common
back injuries, muscle strains, and bone

sprains can be avoided. Learn how to
prepare yourself for physical activity, (
and what to do if an injury does occur.
Lyme Disease Update will be
presented by David G. Beckwith,
Ph.D., Administrator and Clinical
Director, Health Network
Laboratories, on Tuesday, April 26,
from 7 to 8:30 p.m., in the Auditorium
of Lehigh Valley Hospital, Cedar Crest
& 1-78.

With the summer and tick season just
around the corner, the incidence of
Lyme Disease will dramatically
increase. Learn the facts about Lyme
Disease and the precautions you can
take to reduce your risk. Where the
disease is most likely to occur, why
immediate treatment is essential, and
what to do if you've been bitten by a
tick will also be discussed.
Continued on Page 13
Page 12
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Be a Winner at Sports and Nutrition

will be presented by Greg Salem,
exercise specialist, and Donna Scott,
registered dietitian, on Tuesday, May
10 from 7 to 8:30p.m., in the
A~ditorium of Lehigh Valley Hospital,
Cedar Crest & I-78.

There are many myths regarding
exercise and food. Perhaps you have
heard that exercising makes you eat
more, or that if you eat more protein,
you will build more muscle-- these
claims are simply not true. Before you
buy another "magical" supplement,
come and learn the truths about many
food. fallacies. In addition, different
types of exercise and their benefits will
be discussed. You too can feel better
through exercise and healthy nutrition.
Lean Star Cooking will be presented
by Duncan Howdan, Associate
Professor of Culinary Arts,
Northampton County Community
College, and Sandra Barillo, registered
dietitian, on Thursday, May 19, from 7
to 8:30p.m., in the Auditorium of
Lehigh Valley Hospital, Cedar Crest &
I-78.
The Southwestern influence is being
felt everywhere -- think about country
line dancing, cowboy boots, and now
the wonderful Tex-Mex food that is
gaining popularity. In this
presentation, the basics of low-fat
cooking and a demonstration of how to
"legalize" yummy Tex-Mex dishes ~11
be covered. Imagine low-fat taco chips
and fat-free bean dip, followed by
healthy quesadillas and enchiladas.

For more information or to register for
any of the above programs, please
contact the Health Promotion and
Disease Prevention Department at
821-2150.
The Health Promotion and Disease
Prevention Department also offers
numerous other classes and programs
for weight control, stress management,
and smoking cessation which may
benefit your patients. Some of the
upcoming nutrition and weight control
programs include:
• 'lbink Light! Lowfat Living - This

10-week program is a specially
designed lowfat living plan that makes
nutritious eating an easy fact of life.
Beginning April 20, the program will
be held on 10 consecutive Wednesdays
from 7 to 8 p.m., in the O.R.
Conference Room at Lehigh Valley
Hospital, 17th & Chew.
• R.E. W .A.R.D.S. - Have you been
through a weight loss program and
learned the basics of sound nutrition
and weight management? Do you want
more, but you are not sure what? The
R.E.W.A.R.D.S. program is a followup support group for "dieting
veterans." The class will emphasize
practicing stress management,
developing social support systems, and
will also include cooking
demonstrations, and visits from an
image consultant. Beginning April 19,
the group will meet the third Tuesday
of every month from 7 to 8:30p.m., in
Conference Room 6 of Lehigh Valley
Hospital, Cedar Crest & I-78.
Continued on Page 14
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• What's In the Cart?: Shopsmart Heart Health Prop'am - A registered
dietitian will lead group tours
highlighting "heart healthy" food
choices. This will include the "new"
food guide pyramid, convenience food
items, label reading, and special
occasion food selections. The group
tour will be held at the Giant Food
Store at Cedar Crest and Tilghman
Streets in Allentown on Wednesday,
April20, from 9:30 to 11 a.m.;
Tuesday, May 3, from 7 to 8:30p.m.;
and Wednesday, May 11, from 7 to
8:30p.m.

• For Sale or Lease - Springhouse
Professional Center, 1575 Pond Road. Ideal
for .physician's office. Approximately 1,000
sq. ft.
• For Sales or Lease - Medical/ Professional
three-story office building at 1730 Chew
Street, Allentown. Excellent condition with
recent renovations. Approximately 6,800 sq.
ft. for single or multiple specialty practice.
Includes long-term parking lease at
Fairgrounds. Potential telephone and
dictations systems.
• For Sale -- Office building at Northeast
corner of 19th and Turner Streets in
Allentown. Upper level - 2,400 + sq. ft., large
waiting room, two large consultation rooms,
five exam rooms, etc. Lower level - 2,300 +
sq. ft. Parking lot for 16 cars.
• For Lease -- Office to sublet on Monday.
Tuesday, Thursday, and Friday. 950 sq. ft.
Common waiting area. Lakeside Professional
Building, Quakertown.
• For Lease -- Monday time slot available in
the medical office building on the campus of
Gnaden Huetten Memorial Hospital in
Lehighton.
• For Lease -- Medical-professional office
space located on Route 222 in Wescosville.
Two 1,000 sq. ft. offices available or combine
to form larger suite.

For more information about the above
programs, please contact the Health (
Promotion and Disease Prevention
Department at 821-2150.

• For Lease - Slots are currently available for
the Brown Bag suite at Kutztown Professional
Center. Ideal for satellite location.
• For Lease - Large, newly remodeled,
completely furnished medical office space
available for subleasing/time share at Cedar
Crest Professional Park. Top of the line
telephone system. Transcription and
computer system with electronic billing
available.
• For Lease -- Medical office space located in
Peachtree Office Plaza in Whitehall. One suite
with 1,500 sq. ft. (unfinished - allowance
available), and one 1,000 sq. ft. finished suite.
• For Lease -- Specialty practice time-share
space available in a comprehensive health care
facility. Riverside Professional Center, 4019
Wynnewood Drive, Laurys Station. Half- or
full-day slots immediately available.
• For Lease - Professional office space
available in an established psychology and
psychotherapy practice at 45 North 13th
Street, Allentown. Large, warm Victorian
building in a relaxed atmosphere. Secretary
and billing available and included in some
leases. Furnished or unfurnished full offices
and sublets available. Utilities included.
For more information or for assistance in
finding appropriate office space to meet your
needs, contact Joe Pilla, Physician Relations~
Rep, at 402-9856.
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WHO'S NEW
The Who's New section of Medical
Stqff Progress Notes contains an
update of new appointments, address
changes, newly approved priVileges,
etc. Please remember that each
department or unit is responsible for
updating its directory, rolodexes, and
approved privilege rosters.

Medical Staff
Appointment
Andrew J. Pestcoe, DO
Tomkin Otolaryngology Associates, PC
2895 Hamilton Blvd.
Suite 102
Allentown, PA 18104
(610) 432-8551
Department of Surgery
Division of Otolaryngology
Provisional Courtesy

Additional Privileges
Fred l.aufer, MD
Department of Family Practice
Active
Flexible Sigmoidoscopy
Hu&h S. Gallagher, MD
Department of Medicine
Division of Cardiology
Active
Transluminal Extraction Catheter
Atherectomy (TEC)
Stephen T. Olex, DO
Department of Medicine
Division of Cardiology
Active
Transluminal Extraction Catheter
Atherectomy (TEC)

Robert J. Oriel, MD
Department of Medicine
Division of Cardiology
Active
Transluminal Extraction Catheter
Atherectomy (TEC)

Change of Status
Robert J. Gary, MD
Department of Surgery
Division of Urology
From Active to Courtesy
Frank P. Matrone, DO
Department of Family Practice
From Referring to Provisional
Courtesy

Unit Director Appointment
Yehia Y. Mishriki, MD
4S

John D. Nuschke, MD

7B
Division/Section Chief
Appointment
William B. Dupree, MD
Department of Pathology
Chief, Section of GYN Pathology
Vincent R. IAlcente, MD
Department of Obstetrics and
Gynecology
Chief, Division of Gynecology
Chief, Section of Pelvic Reconstructive
Surgery
Gregory J. Radio, MD
Department of Obstetrics and
Gynecology
. Chief, Section of Primary OB/GYN
Continued on Page 16
Page 15
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Practice Changes
Robert B. Kevitch, MD
will be joining Plastic Surgeons
Professional Group, Inc.
(Effective April1, 1994)

Brian SteUo, MD
• No longer associated with
Trexlertown Medical Center
• Joining Family Practice - Lehigh
Valley Health Network
Qobn W. Reinhart, MD)
(Effective April 1, 1994)

Resignation
Stephen J. Barrett, MD
Department of Psychiatry
Consulting

Address Changes
Robert H. Dixon, MD
Emory University
Department of Pediatrics
Division of Critical Care/Emergency
Medicine
1405 Clifton Road
Atlanta, GA 30322

Robert M. Russo, DO
3654 Old Philadelphia Pike
Bethlehem, PA 18015
Brian SteUo, MD
Family Practice- Lehigh Valley Health
Network
·
2200 Hamilton Street
Suite 308
Allentown, PA 18104
(610) 434-7641
(Effective April 1, 1994)

New Fax Number
Judith N. Barrett, MD
(610) 437-2730

Allied Health
Professionals
Appointment
Pamela VandeniJer&, CRNP
Physician Extender
Professional - CRNP
(frauma Service - Michael Rhodes, MD)

Deidre J. Greene, MD
4455 Haverstraw Drive
Dunwoody, GA 30338

Robert B. Kevitch, MD
Plastic Surgeons Professional Group,
Inc.
1230 S. Cedar Crest Blvd., Suite 204
Allentown, PA 18103
(610) 432-1953
(Effective April 1, 1994)
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HEALTII NETWORK
LABORATORIES
A Service of LEH$HVAILEY
HOSPm\1.

Reference Ranges, Sensitivity, Specificity and their
Application to the Diagnostic Accuracy of MI Proides
The terms sensitivity and specificity have
at least two meanings for a laboratorian
namely technical and diapostic. Technical
sensitivity of test deals with the ability of
the test to measure very low levels of an
analyte and specificity, the ability of the
test to measure only the analyte in question
to the exclusion of all other compounds.
However, the diagnostic sensitivity and
specificity defines a laboratory tests'
diagnostic accuracy. This is the concept
that was referred to in relationship to the
new MCKMB measurement in the last
newsletter.
Sensitivity indicates the frequency of
positive test results in patients with a
particular disease, whereas specificity
indicates the frequency of negative test
results in patients without that disease.
The predictive value of a positive test
result indicates the frequency of diseased
patients in all patients with positive test
results. The predictive value of a negative
test result indicates the frequency of nondiseased patients in all patients with
negative test results. The efficiency of a
test indicates the percent of patients (both
diseased and non-diseased) correctly
classified by the test.
By understanding these definitions, how
does the laboratory use them to
set the reference range for a test or
combination of tests? The limits placed on
the reference range have a direct influence
on the diagnostic accuracy for that test. In

the MCKMB study 140 patients were
measured to include a percentage with MI,
a percentage without MI and a percentage
with no MI but another medical condition.
We know that other medical problems can
produce CKMB. Final discharge
diagnoses were obtained for each patient.
This means that the "gold standard" to
evaluate the test is the physicians diagnosis
which along with the testing accuracy
influences the setting of the reference
range and ultimately the diagnostic
accuracy. For each of the 140 patients we
have a measured MCKMB and total CK, a
diagnosis and a calculated relative index
(RI) in percent. From this data we can
determine true positives, false negatives,
true negatives and false positives for any
level of MCKMB and RI. From that data
a series of calculations were performed to
determine sensitivity, specificity, efficiency
and predictive value of positive test and
negative test at MCKMB values from 2-18
and RI percentages from 0-8. This
produced a long table of numbers.
To pick a reference range from these
calculations the nature of the disease being
diagnosed must be considered along with
the following concepts:
A.

Sensitivity of the test may vary
with the severity of the disease and
should be maximized for serious
diseases that are treatable, should
not be missed where false positives
do not lead to serious
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psychological or economic trauma
to the patient. Examples:
infectious disease, hypertension
and hyperlipidemia.
B.

Specificity may vary with the type
of control group and should be
maximized for serious diseases that
are not treatable or curable and/or
a false positive results in serious
psychological or economic trauma
to the patient. Example: HIV,
Tay Sachs, selected metabolic
diseases.

C.

Efficiency should be maximized
for a treatable but serious disease
where false positives and false
negatives are equally serious and
damaging. Examples: MI, SLE,
Diabetes Mellitus.

3.

Now having outlined the protocol and
criteria that the laboratory uses to change a
method and/or introduce new tests why did
Health Network Laboratories change from
electrophoresis to MCKMB? The
efficiency only improved 3% with a loss of
specificity.
1.

Applying these concepts we reviewed the
table of calculations of sensitivity,
specificity and efficiency for this study of
140 patients and chose the reference range
for which the efficieDCJ of the test was
highest.

MCKMB

Electrophoresis is not as accurate a
testing methodology but its
specificity is greater than the new (
mass molecule measurement.
Actually this was appreciated by
most physicians who observed that
negative Mis would always be
negative by the electrophoresis
method. This is to be expected as
the electrophoresis method is not
as sensitive and really did not
detect CKMB below 4 ng/ml.

Within 2 years all clinical
laboratories will use this MCKMB
test. In fact this test with its very
superior antibody is considered to
be the &Wd stanclard for CKMB
testing.
I

Emdency

Sensitivity

Spedfidty

=5

91

84

94

=5

80

93

74

88

64

99

RI% = 4

MCKMB
RI%

=0

Electrophoresis
CKMB = 5
RI

=4

An interpretation of the above abbreviated
table produces the following:
1.

2.

The maximum efficiency occurred
at MCKMB of 5 and RI of 4% our
current reference range.
Dropping the use of the RI
decreased the efficiency of the
testing from 91 to 80. This is why
the RI is one of the parameters
used in our report.

2.

Electrophoresis could not be
provided STAT. The protocol for
the Chest Pain Clinical Path., the
ER and the Trauma Service called
for the rapid diagnosis of a MI and
STAT testing.

3.

The MCKMB test allows for the
completion of the 3 specimen serial
testing protocol within a 16-24 ~
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hour period. This means that
negative patients can be moved
sooner to a less intensive less
costly bed.

(

4.

CKMB is a low molecular weight
enzyme which can be released
from the cytoplasm of the cell
without the cell dying. LD is a
high molecular weight enzyme and
the cell must die to release it into
circulation. The CKMB released
into the blood due to these non MI
"cardiac insults" is detected by the
more analytically sensitive mass
molecule measurement. The

John J. Shane, MD
Chairperson, Pathology

MCKMB serial presentation for this non
MI "insult" will not be the classic rise and
fall of the isoenzyme. Although this
increase in MCKMB due to a cardiac
"insult" may tend to cloud the tests use for
diagnosis of an overt MI, its measurement
is diagnostically important. It is thought
that identifying a patient that has
experienced a non MI cardiac insult is
critical information for the long term
treatment of the patient. This may be the
first documentation that the patient has
experienced a cardiac problem which may
be a precursor to an overt MI. Two
examples of this type of presentation were
illustrated in the last newsletter.

David G. Beckwith, Ph.D.
Clinical Director,
Health Network Laboratories

Gerald E. Clement, Ph.D.
Director,
Immunology/Chemistryrroxicology

Page 19

(

LEHif!HVAILEY
HOSPIT.-\L

P & T Highlights
The following action were
taken at the March 14, 1994
Pharmacy and Therapeutics
Committee Meeting
James A. Giardina,
Director of Pharmacy

FORMULARY ADDITION REQUEST
FOR NOW
Mesalamine (Pentasa, MMD) is a new controlled
release formulation of aminosalicylate, which is
slightly different from Asocol, the other
Mesalamine formulation. It is indicated for the
induction of remission and treatment of patients
with mild to moderate active ulcerative colitis. It
also appears to have efficacy in the treatment of
Crohn's disease. Although mesalamine's
mechanism of action is unknown, it is thought to
work locally rather than systemically, possibly
through modulation of the inflammatory response,
especially leukotriene production. Pentasa is
formulated in an ethylcellulose-coated, 250mg
controlled release capsule, which releases active
medication in a pH dependent fashion to provide
active drug to both the small & large bowel.
Asocol is released in the distal part of the small
bowel, when the gut pH is > 7). Elimination is
thought to occur through the fecal route, with up
to 30% excreted in the urine. Mesalamine should
be used cautiously in hepatically impaired
patients. Mesalamine has caused renal
impairment, including nephropathy and acute &
chronic interstitial nephritis. Because of this, it
should also be used cautiously in renally impaired

patients. Other adverse events include acute
intolerance syndromes (which may be difficult to
distinguish from disease flare up), headache, rash
and GI effects (diarrhea, N/V, abdominal pain, &
dyspepsia). Mesalamine is contraindicated in
patients with hypersensitivity to its ingredients.
It's safety in pregnancy and lactation has not been
established and caution is advised. It is not
recommended for children. Little information is
available on drug interactions, however, because
mesal amine's release & absorption is pH
dependent, potential drug interactions exist with
other medications that alter GI pH. Baseline and
periodic renal and liver function monitoring is
recommended. The usual dose is one gram four
times daily, with approximately 20-30%
absorbed. No comparative studies have been
performed between Pentasa and Asocol. Because
of the theoretical advantage of Pentasa and also
because product usage is low, both agents will be
evaluated after one year. While Pentasa is
generally well tolerated and produces fewer side
effects than Sulfasalazine, approximately 10 20% of patients intolerant to sulfasalazine will not
tolerate Mesalamine.
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FOR SEIZURE CONTROL
Gabapentin (Neurontin, PD) is the second new
antiepileptic agent approved in 1993. It is a
GABA analogue, with an unknown mechanism of
action. It does not interact with GABA receptors.
Gabapentin is indicated as adjunctive therapy in
the treatment of partial seizures with & without
secondary generalization in adults with epilepsy.
Gabapentin's bioavailability is inversely related to
dose, i.e. as the dose increases, the bioavailability
decreases. In the usual dose range, the
bioavailability is about 60% . Food has no effect
on the rate or extent of absorption. It is largely
unbound to plasma protein. Gabapentin is not
appreciably metabolized and is excreted
unchanged in the urine. Gabapentin has an
elimination half life of 5 to 7 hours, which is
directly related to creatinine clearance. In elderly
patients and in patients with impaired renal
function, clearance is reduced. Gabapentin is
removed from the circulation via hemodialysis. It
is contraindicated only in patients who have
demonstrated hypersensitivity to it. Gabapentin
has not been studied in pregnant or nursing
women, and it is recommended only if the
potential benefits outweigh the fetal risk. It has
been shown to be teratogenic in several animal
models. The most common adverse events in
combination with other antiepileptic agents are
somnolence and ataxia (which appear to be dose
related) as well as fatigue and nystagmus. No

drug interactions have been documented,
however, there are reports of increased phenytoin
levels with Gabapentin dosages of 900mg/day &
decreased valproate levels with Gabapentin doses
of 300 & 600mg/day. The importance of these
observations remain to be determined.
Gabapentin is recommended for adults & children
over 12 with a probable effective dose of 9001800mg/day. It is given three times daily without
regard to food. Dose titration is recommended,
with 300mg given on day 1 at bedtime, 300mg
given twice on day 2, then 300mg given three
times on day 3. Dose escalation to 2400mg has
been well tolerated in clinical trials, and some
patients received 3600mg/day for short periods.
The maximum time between doses should not
exceed 12 hours. Table 1 depicts dosage
recommendations in renal impairment and
hemodialized patients.Gabapentin plasma levels
need not be monitored to optimize therapy. If
gabapentin is discontinued and/or alternative
anticonvulsant therapy is added, this should be
done gradually over at least one week.
Gabapentin comes in 1OOmg, 300mg & 400mg
capsules with respective costs of $0.21, $0.47 &
$0.52.
Dosage adjustment in patients with compromised
renal function or undergoing hemodialysis is
recommended as follows:

Table 1 - Gabapentin Dosage in Renal Impairment
Renal Function
Creatinine Clearance
(ml/min)

-

Total Daily Dose
(mg/day)

Dose Regimen
(mg)

>60

1200

400mg TID

30-60

600

300mg BID

15-30

300

300mg QD

<15

150

300mg every other day

---

LD of 300-400mg then
200-300mg p dialysis

Hemodialysis
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FORMULARY DELETIONS
(

Table 2 - Formulary Deletions
Product
Desitin Ointment

Reason
A

Action
R

Formulm Alternative
Critic-Aid +

Saratoga Ointment

D

A,L

Critic-Aid +

Torecan Suppos. •
(thiethylperazine)

D

A,L

Prochlorperazine

Tucks Ointment•

D

A,L

Tucks Pads+

• No longer available

Comments
Limit Desitin to
pediatrics

+ Available from SPD

93 FDA NEW DRUG APPROVALS
Table 3 - 1993 FDA New Drug Approvals
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NURSING IV GUIDELINE CHANGES
Several changes were made to the Nursing IV Guidelines, which are depicted in Table 4. The
concentration for Magnesium Infusions in obstetric patients was also changed from 1Og/500ml to
20g/500ml given conversion to the Horizon IV pump, which has built-in free flow protection.

{

Table 4 - Nursing IV Guideline Additions

MEDS

Phenytoin
Sodium
(Dilantin)

FLOW RATE
FOR
IV PUSH

FLOW RATE
FOR IV
INFUSION

MED/SURG
DILUTION
OR DRIP PUSH

Maximum rate of
SOmg/min in
adults for doses

Doses >soomg
in IOOml NSS
and doses:::,
1500 in 150ml
NSS infused
through a 0.22
micron filter at a
maximum rate
of 25mg/min.
Do not infuse
tbru Dextrose
containing
solutions.

Yes

~SOOmg.

No I.V. push for
doses >500mg.

Pamidronate*
(Aredia)

N/A

60mg & 90mg
doses can be
diluted in a
minimum of
SOOml DSW and
infused over 4
hours. Do not
dilute in
calcium
containing
solutions (ex.
Ringers,
Lactated
Ringers, etc.)

Yes

NURSES
VALIDATED IN
CHEMO
DILUTION
OR DRIP
PUSH

CRITICAL CARE
MONITORED
BEDS
DILUTION
OR DRIP
PUSH

Yes

Yes

Yes

Yes

Yes

No

Yes

No

Yes

No

-

• The Medical Literature and Clinical practice support shorter infusion times than the manufacturer recommended 24 hours.
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. THE TROUBLE WITH DARVOCET
( .1e Committee discussed potential for patients to consume excessive amounts of Acetaminophen (AP AP) from
either AP AP containing combination analgesics or Darvocet N 100 alone. The Committee is aware that
patients have unknowingly been given in excess of 4g/day. Several options that the Committee discussed
included whether Darvocet N 100 should be taken off the formulary or removed from Preprinted Orders.
Darvocet N 100 has received much focus as it is the highest containing APAP product on Formulary. Table 5
lists the AP AP containing products currently on Formulary together with their APAP content. The Committee
asked for a random review to determine daily AP AP intake prior to a decision.

BRAND NAME

APAP CONTENT PER TAB/CAP

Darvocet N 100
Fioricet
Percocet
Tylenol with Codeine
Tylenol
Tylenol Extra Strength

650mg
325mg
325mg
300mg
325mg
500mg

THE FINAL WORD
At the time of standardization on Nizatidine as the preferred oral H2 Blocker, the Pharmacy conducted a
random survey of community prices for the most used oral H2RAs. This data was updated to respond to
Jncems that Nizatidine prices would be dramatically increased in the community to compensate for the special
hospital pricing. The data seem to allay the concern.
Table 5 - Selected Oral H2RA Prices in the Community
DRUG

Axid 150mg
5/93

1/94

PHARMACY A
VARIANCE

$99.17

$103.13
+ 4%

PHARMACY B
VARIANCE

$90.00

$100.23
+ 11%

c

$97.99

PHARMACY D
VARIANCE
PHARMACY E
ll VARIANCE

DATE OF
SURVEY

PHARMACY
VARIANCE

Pepcid 20mg
5/93
$98.48

1194

Zantac 15()mg
5/93

1194

$102.58
+4%

$109.54

$113.92
+ 4%

$88.89

$ 96.99
+ 9%

$92.69

$ 94.80
+ 2%

$ 97.99
0%

$90.99

$ 96.99
+7%

$91.99

$ 96.99
+5%

$80.19

$ 76.79
-4%

$84.88

$ 85.49
+.0.7%

$76.39

$ 79.56
+4%

$89.95

$ 93.50
+4%

$89.50

$ 92.95
+ 4%

$98.95

$102.75
+4%

.,

pt\03I494.hi
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